tirzepatide with trt CME INDIA on X: "“Tirzepatide Shown to Tackle Hypogonadism” from ENDO 2025: 📰 CME INDIA – Clinical Pearls: in Obesity-Associated Hypogonadism @Rssdi_official @IndiaESI @AskDrShashank @banshisaboo @DrAmbrishMithal @dramitaol @KapoorNitinDr Curious about Tirzepatide injection therapy

Participants on the highest dose (15 mg) achieved an average weight reduction of 22.9% over three years, marking one of the longest documented sustained weight loss effects in obesity pharmacotherapy

PD is becoming a severe public health concern with a global prevalence of roughly 6.1 million people in 2016 and a projected to be twice by 2040 (2)

While some scarring is inevitable after any surgical procedure, overly large, raised, or discolored scars suggest that the healing process was compromised

4 mm 31G or 32G is the modern default

Simultaneous quantification of glutathione, glutathione disulfide and [PMID: 35509159] Laboratory literature summary: Simultaneous quantification of glutathione, glutathione disulfide and glutathione-S-sulfonate in grape and wine using LC-MS/MS

Potential Benefits: Phase II trials show 50% pain reduction in small fiber neuropathy May support neuroprotection without erythropoietic effects Suggested Clinical Dosing Range: 4 mg twice daily subcutaneous (research protocols) Dosing is individualized and determined by a qualified medical provider